Advertisement
New Zealand markets open in 9 hours 52 minutes
  • NZX 50

    11,803.28
    -49.52 (-0.42%)
     
  • NZD/USD

    0.5917
    -0.0004 (-0.06%)
     
  • ALL ORDS

    7,937.90
    +35.90 (+0.45%)
     
  • OIL

    81.29
    -0.61 (-0.74%)
     
  • GOLD

    2,316.20
    -30.20 (-1.29%)
     

Novartis’s Sandoz in Q2 2018

Novartis’s Sandoz in Q2 2018

Sandoz is Novartis’s (NVS) generics business and is a market leader in differentiated generics. Sandoz reported nearly flat revenues at ~$2.46 billion in Q2 2018 compared to $2.45 billion in the second quarter of 2017. Revenue growth was driven by a 2% favorable impact of foreign exchange, offset by a 2% decline in operating revenues.